Clinical care and technical recommendations for 90yttrium microsphere treatment of liver cancer
- 9 June 2010
- journal article
- review article
- Published by Wiley in Journal of Medical Imaging and Radiation Oncology
- Vol. 54 (3), 178-187
- https://doi.org/10.1111/j.1754-9485.2010.02167.x
Abstract
Selective internal radiation therapy (SIRT) with (90)yttrium microspheres is a relatively new clinical modality for treating non-resectable malignant liver tumours. This interventional radiology technique employs percutaneous microcatheterisation of the hepatic arterial vasculature to selectively deliver radioembolic microspheres into neoplastic tissue. SIRT results in measurable tumour responses or delayed disease progression in the majority of eligible patients with hepatocellular carcinoma or hepatic metastases arising from colorectal cancer. It has also been successfully used as palliative therapy for non-colorectal malignancies metastatic to the liver. Although most adverse events are mild and transient, SIRT also carries some risks for serious and--rarely--fatal outcomes. In particular, entry of microspheres into non-target vessels may result in radiation-induced tissue damage, such as severe gastric ulceration or radiation cholecystitis. Radiation-induced liver disease poses another significant risk. By careful case selection, considered dose calculation and meticulous angiographic technique, it is possible to minimise the incidence of such complications to less than 10% of all treatments. As the number of physicians employing SIRT expands, there is an increasing need to consolidate clinical experience and expertise to optimise patient outcomes. Authored by a panel of clinicians experienced in treating liver tumours via SIRT, this paper collates experience in vessel mapping, embolisation, dosimetry, microsphere delivery and minimisation of non-target delivery. In addition to these clinical recommendations, the authors propose institutional criteria for introducing SIRT at new centres and for incorporating the technique into multidisciplinary care plans for patients with hepatic neoplasms.Keywords
This publication has 35 references indexed in Scilit:
- Radiation Lobectomy: Preliminary Findings of Hepatic Volumetric Response to Lobar Yttrium-90 RadioembolizationAnnals of Surgical Oncology, 2009
- Yttrium-90 microsphere induced gastrointestinal tract ulcerationWorld Journal of Surgical Oncology, 2008
- Liver disease induced by radioembolization of liver tumorsCancer, 2008
- Radiation Dose Limits and Liver Toxicities Resulting from Multiple Yttrium-90 Radioembolization Treatments for Hepatocellular CarcinomaJournal of Vascular and Interventional Radiology, 2007
- Gastrointestinal Complications Associated with Hepatic Arterial Yttrium-90 Microsphere TherapyJournal of Vascular and Interventional Radiology, 2007
- Safety and efficacy of Y-90 microsphere treatment in patients with primary and metastatic liver cancer: The tumor selectivity of the treatment as a function of tumor to liver flow ratioJournal of Translational Medicine, 2007
- Radioembolization with Yttrium-90 Microspheres: A State-of-the-Art Brachytherapy Treatment for Primary and Secondary Liver MalignanciesJournal of Vascular and Interventional Radiology, 2006
- Randomised phase 2 trial of SIR‐Spheres® plus fluorouracil/leucovorin chemotherapy versus fluorouracil/leucovorin chemotherapy alone in advanced colorectal cancerJournal of Surgical Oncology, 2004
- Clinical evaluation of the partition model for estimating radiation doses from yttrium-90 microspheres in the treatment of hepatic cancerEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Selective internal radiation therapy: Distribution of radiation in the liverEuropean Journal of Cancer and Clinical Oncology, 1989